Nestlé plans to introduce a series of meals in the US tailored to complement the use of GLP-1 weight-loss medication.The Swiss corporation stated that the Vital Pursuit products are rich in protein, provide ample fiber, include...
Nestle SA CEO Mark Schneider downplayed the impact of GLP-1 weight-loss drugs on the world's largest food company, emphasizing the company's focus on expanding its range of products with reduced calorie content.In a Bloomberg TV interview,...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Accept CookiesPrivacy policy
